McLeod C, Dymock, Flanagan KL, Plebanski M, et al. The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): the immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-<70 years old. J Infect 2024 Sep 26:106286. doi: 10.1016/j.jinf.2024.106286.
PMID: 39341401